DNA

9.09

6.58% -0.64

Dopo l'orario di chiusura: 9.14 0.05 +0.55%

Ginkgo Bioworks Holdings Inc (DNA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché DNA Giù? Forum Previsione

Precedente Chiudi:

$9.73

Aprire:

$9.73

Volume 24 ore:

1.08M

Relative Volume:

0.87

Capitalizzazione di mercato:

$593.80M

Reddito:

$141.31M

Utile/perdita netta:

$-297.87M

Rapporto P/E:

-1.6854

EPS:

-5.3933

Flusso di cassa netto:

$-168.20M

1 W Prestazione:

-12.60%

1M Prestazione:

+14.48%

6M Prestazione:

-1.62%

1 anno Prestazione:

-15.76%

Intervallo 1D:

$8.84

$9.805

Intervallo di 1 settimana:

$8.75

$10.58

Portata 52W:

$5.37

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Nome

Ginkgo Bioworks Holdings Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

(877) 442-5362

Indirizzo

27 DRYDOCK AVENUE, BOSTON

Dipendente

485

Cinguettio

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

DNA's Discussions on Twitter

Compare DNA vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DNA Ginkgo Bioworks Holdings Inc	9.09	593.80M	141.31M	-297.87M	-168.20M	-5.3933
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-15	Downgrade	BTIG Research	Neutral → Sell
2024-05-10	Downgrade	William Blair	Mkt Perform → Underperform
2023-11-14	Downgrade	Raymond James	Outperform → Mkt Perform
2023-11-09	Downgrade	BTIG Research	Buy → Neutral
2023-06-02	Downgrade	Goldman	Neutral → Sell
2023-05-11	Downgrade	William Blair	Outperform → Mkt Perform
2022-11-29	Iniziato	Berenberg	Buy
2022-10-04	Iniziato	Morgan Stanley	Equal-Weight
2022-05-18	Downgrade	BofA Securities	Neutral → Underperform
2022-03-02	Ripresa	Cowen	Outperform
2022-02-23	Iniziato	Goldman	Neutral
2022-02-01	Iniziato	BofA Securities	Neutral
2022-01-28	Iniziato	BofA Securities	Buy
2022-01-07	Iniziato	BTIG Research	Buy
2021-11-29	Iniziato	Jefferies	Buy
2021-10-13	Iniziato	Raymond James	Outperform
2021-10-12	Iniziato	William Blair	Outperform
2021-09-20	Iniziato	HSBC Securities	Buy

Mostra tutto

Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie

Jul 09, 2026

Ginkgo Bioworks Holdings' Stock Sinks To US$9.07, But Insiders Sold Even Lower - simplywall.st

Jul 09, 2026

Jul 05, 2026

Earnings call transcript: Ginkgo Bioworks Q1 2026 sees revenue drop, restructuring efforts noted - Investing.com

Jul 05, 2026

Jul 04, 2026

ETFs Investing in Ginkgo Bioworks Holdings, Inc. Class A Stocks - TradingView

Jul 04, 2026

Jul 03, 2026

Most Volatile Stocks in the US (July 2026) - Investing.com

Jul 03, 2026

Jul 02, 2026

Ginkgo Bioworks Holdings Inc Warrant 2021-01.08.26 on Ginkgo Bioworks -A Financial Disclosures & SEC Filings - TradingView

Jul 02, 2026

Jun 29, 2026

Ginkgo Bioworks (DNA) Holds Near $10.21 as Stock Consolidates in Tight RangeIron Condor Alert - dars.gov.et

Jun 29, 2026

Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Ginkgo Bioworks Holdings, Inc.(NYSE: DNA) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think - The Motley Fool

Jun 28, 2026

Ginkgo Bioworks (DNA) Q1 2026 Earnings: EPS Misses Estimates, Stock Surges Over 7%Buyback Announcement Report - dars.gov.et

Jun 28, 2026

Jun 27, 2026

Enterprise value to revenue forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Price to earnings forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Jun 26, 2026

Price to sales forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 26, 2026

Ginkgo Bioworks (DNA) Rallies 6.27% as Biotech Sector Shows Renewed StrengthInitial Balance - dars.gov.et

Jun 26, 2026

Jun 25, 2026

Ginkgo Bioworks Holdings, Inc. Class A Actuals & Estimates (NYSE:DNA) - TradingView

Jun 25, 2026

9L40 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Price to sales forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

Price to earnings forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

Price to book forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

DNA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 23, 2026